Laurent Simons entered primary school at two, a milestone that set the tone for a prodigious academic trajectory. He sketched quantum equations by nine and joined Eindhoven University of Technology in 2018, working on a brain‑on‑a‑chip prototype that tested neuron‑drug interactions.
— In 2019, a clash over course pacing forced Simons to leave Eindhoven, a decision he described as "a necessary pause". He then transferred to the University of Antwerp, where he completed a physics bachelor at 11 and a quantum physics master at 12, each in record time.
The first doctoral milestone arrived on November 17, 2025, when he defended a thesis on Bose‑Einstein condensates and polarons, earning a PhD at 15. The University of Antwerp’s website highlighted his work on ultracold bosonic gases, a field usually reserved for senior researchers.
Now, in 2026, Simons has pivoted to medical science, enrolling in a second doctorate at the Helmholtz Centre in Munich. His project fuses artificial intelligence with biomedical research to map the complex biology of ageing, a pursuit he frames as solving a "huge puzzle" of disease.
— The project will soon release preliminary data, with Simons planning to launch an AI‑driven clinical trial targeting cardiovascular disease, a condition that has already claimed both of his grandparents.
The next step, according to Helmholtz officials, is a publication of the full study in the first quarter of 2027, followed by a pilot trial in a German university hospital. If successful, the research could redefine preventive medicine for ageing populations worldwide.